4-aminopyridine has been researched along with Orphan Diseases in 1 studies
Orphan Diseases: Rare diseases that have not been well studied.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nicholl, DJ | 1 |
| Hilton-Jones, D | 1 |
| Palace, J | 1 |
| Richmond, S | 1 |
| Finlayson, S | 1 |
| Winer, J | 1 |
| Weir, A | 1 |
| Maddison, P | 1 |
| Fletcher, N | 1 |
| Sussman, J | 1 |
| Silver, N | 1 |
| Nixon, J | 1 |
| Kullmann, D | 1 |
| Embleton, N | 1 |
| Beeson, D | 1 |
| Farrugia, ME | 1 |
| Hill, M | 1 |
| McDermott, C | 1 |
| Llewelyn, G | 1 |
| Leonard, J | 1 |
| Morris, M | 1 |
1 other study available for 4-aminopyridine and Orphan Diseases
| Article | Year |
|---|---|
Open letter to prime minister David Cameron and health secretary Andrew Lansley.
Topics: 4-Aminopyridine; Amifampridine; Drug Costs; Drug Industry; European Union; Humans; Licensure; Orphan | 2010 |